Executive Order 13139

Executive Order 13139— entitled Improving Health Protection of Military Personnel Participating in Particular Military Operations — as an executive order (EO) issued by U.S. President Bill Clinton on 30 September 1999. It outlines the conditions under which Investigational New Drug (IND) and off-label pharmaceuticals can be administered to U.S. service members. An “off-label" indication is a use of a drug in a manner (or for a condition) other than that for which they were originally licensed.

Executive Order 13139

Executive Order 13139— entitled Improving Health Protection of Military Personnel Participating in Particular Military Operations — as an executive order (EO) issued by U.S. President Bill Clinton on 30 September 1999. It outlines the conditions under which Investigational New Drug (IND) and off-label pharmaceuticals can be administered to U.S. service members. An “off-label" indication is a use of a drug in a manner (or for a condition) other than that for which they were originally licensed.